Some insurers in the ACA’s small group market are citing tariffs, particularly those affecting prescriptions drugs, as a reason for higher-than-expected premium increases.
Recent Posts
- Generali unveils Redion brand for global Care platform
- Mark Trumper succeeds Jonathan Jackson as Previsico CEO
- CyberCube and UIB identify Asia as a major growth market for cyber insurance
- Swiss Re announces new Market Heads
- Middle East conflict creates limited Q1’26 pressure for global specialty P&C insurers: Morningstar DBRS